Country: Netherlands
Language: English
Source: HMA (Heads of Medicines Agencies)
ramipril 0.62 mg
Intervet Deutschland GmbH
QC09AA05
Tablet
ramipril
Dogs Non Food
2010-06-08
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vasotop P 0.625mg, tablet for dogs In DK, IE, NO and SE, the name of the veterinary medicinal product is Vasotop 0.625 mg tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance. 1 tablet Vasotop P 0.625mg contains: 1.25 mg Ramipril Excipients: Colouring matters: Brown ferric oxide (E172): 1.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Beige oblong tablet with score line on both sides. Embossing : One side : “V” on both sides of the score line The tablets can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of congestive heart failure (according to New York Heart Association (NYHA) classification grade II, III & IV) caused by valvular insufficiency due to chronic degenerative valvular heart disease (endocardiosis) or cardiomyopathy, with or without adjunct therapy with the diuretic furosemide and / or the cardiac glycosides digoxin or methyldigoxin. Class Clinical signs II Fatigue shortness of breath, coughing etc. become evident when ordinary exercise is exceeded. Ascites may appear at this stage. III Comfortable at rest, but exercise capacity is minimal IV No capacity for exercise. Disabling clinical signs are present even at rest. In patients treated concurrently with the product and furosemide the dose of the diuretic can be reduced to achieve the same diuretic effect as treatment with furosemide alone. Read the complete document